Skip to main content

Reply to the letter by Finsterer et al. concerning the paper: “Affection of immune-cells by a C10orf2 mutation manifesting as mitochondrial myopathy and transient sensory transverse syndrome” by Galassi G. et al.

This is a preview of subscription content, access via your institution.

References

  1. Finsterer J, Zarrouk-Mahjoub S (2017) Affection of immune cells by a C10orf2 mutation manifesting as mitochondrial myopathy and transient sensory transverse syndrome. Acta Neurol Belg. doi:10.1007/s13760-017-0821-8

    PubMed  Google Scholar 

  2. Galassi G, Maggi L, Lamantea L, Ariatti A, Malagoli M (2017) C10ORF2 mutation associated with progressive external ophthalmoplegia and clinically isolated syndrome. Acta Neurol Belg. doi:10.1007/s13760-017-0793-8

    Google Scholar 

  3. Cotton F, Weiner HL, Jolesz FA, Guttmann CR (2003) MRI contrast uptake in new lesions in relapsing—remitting MS followed at weekly intervals. Neurology 25:640–646

    Article  Google Scholar 

  4. Swanton JK, Ferrnando K, Dalton CM, Miszkiel KA, Thompson AJ, Plant GT et al (2006) Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 77:830–833

    CAS  Article  PubMed  Google Scholar 

  5. Gropman AL (2013) Neuroimaging in mitochondrial disorders. Neurotherapeutics 10:273–285

    Article  PubMed  Google Scholar 

  6. Horwitz H, Degn M, Modvig S, Larsson HB, Wanscher B, Frederiksen JL (2012) CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis. J Neurol 259:2616–2620

    Article  PubMed  Google Scholar 

  7. Hardmaier M, Leocani L, Fuhr P (2017) A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials. Mult Scler. doi:10.1177/1352458517707265

    Google Scholar 

  8. Martinelli V, Dalla Costa G, Messina MJ, Di Maggio G, Sangalli F, Moiola L et al (2017) Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndrome. Acta Neurol Scand. doi:10.1111/ane.12761

    PubMed  Google Scholar 

  9. Bourre MD, Zéphir H, Ongagna JC, Cordonnier C, Collongues N, Debette S et al (2012) Long term follow up of acute partial transverse myelitis. Arch Neurol 69:357–362

    Article  PubMed  Google Scholar 

  10. Gaetani L, Mignarri A, Di Gregorio M, Sarchielli P, Malandrini A, Cardaioli E et al (2016) Multiple sclerosis and chronic progressive external ophthalmoplegia associated with large scale mitochondrial DNA single deletion. J Neurol 263:1449–1451

    Article  PubMed  Google Scholar 

  11. Sadeghian M, Mastrolia V, Haddad AR, Mosley A, Mullali G, Schiza D et al (2016) Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis. Sci Rep 6:33249. doi:10.1038/srep33249

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuliana Galassi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Galassi, G., Maggi, L., Lamantea, E. et al. Reply to the letter by Finsterer et al. concerning the paper: “Affection of immune-cells by a C10orf2 mutation manifesting as mitochondrial myopathy and transient sensory transverse syndrome” by Galassi G. et al.. Acta Neurol Belg 117, 971–972 (2017). https://doi.org/10.1007/s13760-017-0822-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-017-0822-7